A study has given insights into the use and perception of telemedicine during the COVID-19 pandemic among people with Type 1 diabetes.
Researchers from the University of Bern, Switzerland distributed an online questionnaire via social media between 24 March and 5 May 2020 – 7,477 people from 89 countries responded, and the majority were from the USA (40.6%), UK (17.5%), or Switzerland (9.8%).
Overall, 28% said they had taken part in remote consultations, while 31% said they planned to use telemedicine in the future, and approximately 80–90% of respondents thought telemedicine was useful.
“Type 1 diabetes might be particularly well suited to telemedicine because a lot of consultations are mostly based around review of glucose data and conversations about therapy,” and there is “increasing use of continuous glucose monitoring, insulin pumps, and smart insulin pens alongside cloud- or screen-based data-sharing,” said co-author Sam Scott at the virtual European Association for the Study of Diabetes (EASD) conference in September.
Read more HERE.
